Related Experiment Videos
The delivery of ivermectin (Mectizan)
1The Johns Hopkins Bloomberg School of Public Health, Department of International Health, Baltimore, MD 21205, USA. gburnham@jhsph.edu
Tropical Medicine & International Health : TM & IH
|April 14, 2004
Summary
Ivermectin (Mectizan) distribution has transformed onchocerciasis control through partnerships and community engagement. Sustaining these efforts is key to long-term disease management in impoverished regions.
Area of Science:
- Global health
- Tropical medicine
- Parasitology
Background:
- Onchocerca volvulus infection, or river blindness, causes significant morbidity.
- The development and distribution of ivermectin (Mectizan) marked a turning point in disease management.
Purpose of the Study:
- To highlight the impact of ivermectin on onchocerciasis control.
- To discuss the collaborative efforts and community involvement crucial for program success.
- To identify challenges in sustaining long-term disease control programs.
Main Methods:
- The study reviews the historical development and distribution strategies of ivermectin.
- It emphasizes the role of multi-sectoral partnerships, including pharmaceutical companies, international organizations, governments, and NGOs.
- Community-based drug delivery models are examined as a key component.
Main Results:
- Ivermectin has dramatically altered the impact of Onchocerca volvulus infection.
- Successful implementation relied on strong partnerships and innovative delivery tools.
- High community engagement and enthusiasm for self-delivered ivermectin were critical success factors.
Conclusions:
- Sustaining ivermectin distribution requires integration into existing health services, especially in challenging regions.
- Continued commitment is vital as disease awareness wanes and elimination goals remain distant.
- The success of the ivermectin program underscores the importance of sustained, collaborative public health initiatives.